Sheaff Brock Investment Advisors, LLC Bio N Tech Se Transaction History

Sheaff Brock Investment Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$126.25 - $231.85 $142,536 - $261,758	-1,129 Closed	0 $0
Q4 2021 Jun 02, 2022	BUY	$216.64 - $362.52 $4,982 - $8,337	23 Added 2.08%	1,129 $291,000
Q4 2021 Feb 03, 2022	SELL	$216.64 - $362.52 $4,982 - $8,337	-23 Reduced 2.04%	1,106 $285,000
Q3 2021 Jun 02, 2022	BUY	$205.93 - $447.23 $4,736 - $10,286	23 Added 2.08%	1,129 $308,000
Q3 2021 Nov 03, 2021	BUY	$205.93 - $447.23 $19,563 - $42,486	95 Added 9.4%	1,106 $302,000

Q2 2021 Jun 02, 2022	BUY	$113.32 - $241.49 $1,699 - $3,622	15 Added 1.51%	1,011 $226,000
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $112,866 - $240,524	996 New	996 $223,000

326

40.4M

1.31M

1.37M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $19.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.